The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
Hypercholesterolemia is a clinically relevant condition with an ascertained role in atherogenesis. In particular, its presence directly correlates to the risk of atherosclerotic cardiovascular disease (ASCVD). As known, cardiovascular diseases pose a significant economic burden worldwide; however, a...
Saved in:
Main Authors: | Pietro Ferrara, Danilo Di Laura, Paolo A Cortesi, Lorenzo G Mantovani |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f75a38b6008d431e9c3941c8efc6109f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
by: Hirotaka Fukami, et al.
Published: (2021) -
Genetic basis of hypercholesterolemia in adults
by: Seyedmohammad Saadatagah, et al.
Published: (2021) -
PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
by: Samip Sheth, et al.
Published: (2021) -
Dyslipidemias in diabetes
by: HELENA W RODBARD
Published: (2004) -
A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia
by: Xiaoyue Ge, et al.
Published: (2021)